(Q33511653)

27 July 2017

0 references

1 reference

title

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases (English)

1 reference

27 July 2017

0 references

S Boonen

1

1 reference

27 July 2017

R Kay

2

1 reference

27 July 2017

C Cooper

3

1 reference

27 July 2017

P Haentjens

4

1 reference

27 July 2017

D Vanderschueren

5

1 reference

27 July 2017

F Callewaert

6

1 reference

27 July 2017

K Milisen

7

1 reference

27 July 2017

S Ferrari

8

1 reference

27 July 2017

publication date

20 October 2009

1 reference

International Journal of Clinical Practice

27 July 2017

published in

1 reference

27 July 2017

volume

63

1 reference

27 July 2017

issue

12

1 reference

27 July 2017

page(s)

1792-1804

1 reference

Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02206.X

Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02206.X

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02206.X

Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02206.X

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02206.X

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1007/S00198-006-0172-4

Identifiers

DOI

10.1111/J.1742-1241.2009.02206.X

1 reference

27 July 2017

1 reference